e-learning
resources
European Respiratory Review
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The future of bronchodilation: looking for new classes of bronchodilators
Mario Cazzola, Paola Rogliani, Maria Gabriella Matera
Source:
Eur Respir Rev, 28 (154) 190095; 10.1183/16000617.0095-2019
Journal Issue:
December
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mario Cazzola, Paola Rogliani, Maria Gabriella Matera. The future of bronchodilation: looking for new classes of bronchodilators. Eur Respir Rev, 28 (154) 190095; 10.1183/16000617.0095-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Are bronchodilator drugs really useful in COPD?
Source: Eur Respir J 2001; 18: Suppl. 33, 94s
Year: 2001
Is it time to move away from short-acting beta-agonists in asthma management?
Source: Eur Respir J, 53 (4) 1802223; 10.1183/13993003.02223-2018
Year: 2019
Long-acting bronchodilators in COPD: where are we now and where are we going?
Source: Breathe 2014; 10:110-120
Year: 2014
Therapeutic approaches beyond positive airway pressure and bronchodilators: time for rehabilitation?
Source: Sleep and Breathing Conference 2021
Year: 2021
A new class of bronchodilator improves lung function in COPD: a trial with GSK961081
Source: Eur Respir J 2013; 42: 972-981
Year: 2013
Emerging inhaled bronchodilators: an update
Source: Eur Respir J 2009; 34: 757
Year: 2009
An inhaled “bifunctional” dual PDE3/4 inhibitor provides additional short-term improvements in lung function compared to existing classes of bronchodilator: implications for future treatment of COPD
Source: Eur Respir J, 52 (5) 1801675; 10.1183/13993003.01675-2018
Year: 2018
Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment
Source: Eur Respir J 2008; 31: 1145-1147
Year: 2008
Long-acting bronchodilators and synergistic interaction: a challenge across the currently available LABA/LAMA combinations
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
Inhaled beta2-agonists in asthma management: an evolving story
Source: Breathe 2016; 12: 375-377
Year: 2016
Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Switching to maintenance and reliever inhaled corticosteroid/long acting beta agonist: a real-world pilot evaluation in a regional paediatric difficult asthma clinic.
Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world
Year: 2020
Anti-asthmatic drugs: treatment of athletes and exercise-induced bronchoconstriction
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-22-7, page=73
Year: 2005
The effect of additional use of short-acting beta2 agonist on exercise tolerance in patients with COPD on regular long-acting bronchodilators treatments
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Individual and differential treatment responses to once-daily long acting bronchodilators, glycopirronium and indacaterol, and combination of both drugs in the patients with moderate or severe COPD
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Inhaled therapies: can they breathe new life into asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019
Inhaler preference comparing two alternative dual bronchodilator regimens
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016
The effect of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A real practice analysis in Italy
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
A new combination therapeutic approach challenging the current dogma of using inhaled corticosteroids as maintenance only to control asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 666s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept